Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca expands technological investment in new Cambridge lead discovery centre
-
TAGRISSO™ (AZD9291) approved by the US FDA for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
-
AstraZeneca presents positive new data on anifrolumab in lupus at American College of Rheumatology Annual Scientific Meeting
-
AstraZeneca strengthens Cardiovascular and Metabolic disease portfolio with acquisition of ZS Pharma
-
Year To Date and Q3 2015 Results
-
FDA Advisory Committee recommends the approval of lesinurad for gout patients
-
AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations
-
AstraZeneca opens new manufacturing facilty to support continued growth in Russia
-
AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination
-
New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis
Latest articles and press releases
All of our latest press releases and articles are available to explore
